Keywords: AUC; area under the curve; API; active pharmaceutical ingredient; SRL; Sirolimus; CYP; cytochrome P450; PgP; P-glycoprotein; FaSSIF/FeSSIF; Fasted/Fed State Stimulating Intestinal fluid; PAMPA; parallel artificial membrane permeation assay; SDS; sodium do